EUVIMED · CrossrefZeitschrift
Cancer
ISSN 0008-543X · Wiley
Neueste Artikel
Patient reimbursement in therapeutic cancer clinical trials: An 18‐year multicenter experience
Bispecific antibodies targeting B‐cell maturation antigen in multiple myeloma: Current clinical applications, challenges and future directions
Issue Information
Correction to “Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis”
Population‐level diagnostic and radiation treatment trends of low‐risk prostate cancer
Telehealth tobacco cessation doubles quit rates in patients with cancer
CAR T‐cell data indicate durable disease control, potential cure
Novel therapies create potential new options for patients with advanced breast cancer
The evolving role of perioperative systemic therapy in bladder cancer
A multicenter, prospective, phase 2 trial on proton re‐irradiation for patients with previously treated head and neck cancer
Risk factors and outcome of children and young adults with initially unresected nonrhabdomyosarcoma soft tissue sarcoma: An analysis from the International Soft Tissue Sarcoma Consortium
Issue Information
Generative artificial intelligence in medical oncology: A clinically focused narrative review of large language, vision‐language, and agentic artificial intelligence systems
Body mass index at diagnosis, postdiagnosis change, and role of metabolic comorbidities in relation to survival in nonmetastatic renal cell carcinoma patients
Structured rehabilitation for terminal cancer: Aligning the evidence with the setting that funds it
Reply to “Structured rehabilitation for terminal cancer: Aligning the evidence with the setting that funds it”
Maintenance therapy with low dose cyclophosphamide does not increase the risk of second malignancies: The European Pediatric Soft Tissue Sarcoma Study Group RMS2005 study experience
Decision regret following rapid genetic testing at the time of breast cancer diagnosis
Eltrombopag during induction chemotherapy in older patients with newly diagnosed acute myeloid leukemia is safe and reduces platelet transfusion requirements: The EPAG‐2015 French Innovative Leukemia Organization phase 2 randomized trial
Liposomal irinotecan and capecitabine plus bevacizumab as second‐line therapy in metastatic colorectal cancer: A multicenter, single‐arm study
Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower‐risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo‐controlled trial
All‐oral regimen approved for older patients with AML who are ineligible for intensive chemotherapy
Study raises important questions about the clinical utility of multicancer early detection testing
Tile‐based radiation therapy may be new standard of care for patients with surgical brain metastases
Annual Report to the Nation on the Status of Cancer, featuring 21st century progress against lung cancer
Issue Information
Impact of post‐chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children’s Oncology Group AREN0532, AREN0533, and AREN03B2 studies
Outcomes of adult patients with Li‐Fraumeni syndrome and myeloid neoplasms
Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis
External validation of the NADIR model for early prostate‐specific antigen response prediction in enzalutamide‐treated metastatic hormone‐sensitive prostate cancer: An analysis of the ARCHES trial
Jahrgänge
2026 · 2972025 · 6312024 · 5352023 · 5092022 · 5922021 · 6552020 · 7052019 · 6282018 · 6502017 · 6932016 · 5802015 · 6892014 · 6332013 · 6792012 · 8272011 · 7592010 · 8232009 · 6982008 · 8502007 · 7702006 · 8692005 · 8182004 · 8112003 · 8622002 · 9192001 · 9432000 · 1.2681999 · 1.2881998 · 1.1941997 · 1.1631996 · 1.3621995 · 8481994 · 1.0171993 · 1.3091992 · 9881991 · 1.0321990 · 9731989 · 8881988 · 8801987 · 920
EUVIMED